Erasing Humanity: Evidence of VMAT2 Deletion

Make this go viral!

by Dr. Ariyana Love

In my latest interview with Greg Reese on InfoWars, I mentioned the AstraZeneca trial in September of 2020, where COVID-19 mRNA vaccine recipients reported that they could no longer feel God.

“They’ve killed God; I can’t feel God anymore – my Soul is dead,” a trial participant reported.

This phenomenon of disconnect is an all too common observation after COVID-19 vaccination. Since early 2021, clients have repeatedly told me they can no longer feel God. They also could not feel their connection to other people. They felt the same disconnect when immersed in nature, which was the most terrifying thing. One client told me the extreme physical pain he was in was nothing compared to the loss of contentedness that he felt. Another client told me she would rather die than live without feeling her humanity and connectedness.

I learned about the VMAT2 Gene early in 2021. It’s otherwise known as the “God Gene”. In his book The God Gene: How Faith is Hardwired into Our Genes, Dean Hamer argues that a variation in the VMAT2 gene plays a key role in one’s openness to spiritual experiences. Without it, you can’t feel God.

In a leaked video dated April 13th, 2005, Dean Hamer is giving a presentation to DoD officials inside the Pentagon. Some have mistaken this for Bill Gates.

In the video, Dean Hammer reveals his desire to reduce the VMAT2 gene in humans.

The VMAT2 gene is located on chromosome 10. The scientific name for VMAT2 is “vesicular monoamine transporter 2.” This protein carries key neurotransmitters such as dopamine and serotonin, which play a vital role in neural activities and social behaviors.

Serotonin production is almost exclusively produced in neurons originating in the brain stem, the root of our VMAT2 system. It controls the largest and most complex efferent system in the human brain. VMAT2 controls the main functions in the central nervous system, from sequestering toxins to providing conditions for the release of monoaminergic neurotransmitters, which are (1) serotonin, (2) dopamine, (3) norepinephrine, (4) epinephrine, and (5) histamine.

(1) Serotonin and (2) dopamine are tiny molecules produced in our brain that make us happy. (3) Norepinephrine is a neurotransmitter or chemical messenger and a hormone that helps transmit nerve signals across nerve endings to another nerve cell, muscle cell, or gland cell. It increases arousal and alertness, promotes vigilance, enhances the formation and retrieval of memory, and focuses attention. (4) Epinephrine is also a neurotransmitter and hormone that plays a key role in your body’s “fight-or-flight” response, otherwise known as adrenaline. (5) Histamine regulates your sleep-wake cycle and cognitive function. Histamine regulates immune response communication, regulating gut physiological functions and acting as a neurotransmitter for the brain, spinal cord, and uterus. Histamine exerts regulatory functions in innate and adaptive immune responses. Histamine activates intracellular pathways for cellular communication and returns to homeostasis after injury. Histamine plays a critical role in inflammation regulation.

VMAT2 safeguards B-cells from dopamine cytotoxicity. B-cells (lymphocytes) are a key player in the adaptive immune response. VMAT2 is responsible for packaging these neurotransmitter molecules and delivering them to synapses in your brain. VMAT2 is the only vesicular monoamine transporter expressed in central nervous system neurons, which controls your CNS entirely. Knockout of the VMAT2 gene reduces these five neurotransmitters, which leads to an array of devastating bodily injuries.

The VMAT2 gene regulates the monoamine systems of the brain. These systems are crucial for normal brain function, arousal, mood, movement, and motivation, and their dysfunction or deletion is highly correlated with neuropsychiatric and neurological disorders. This explains why COVID-19 vaccine-injured persons have a loss of motor function.

VMAT2 knockout

VMAT2 deletion is accomplished using the “SLC18A2 cDNA ORF clone, Homo sapiens (human)”. “ORF” means open reading frames for no-stop codons. Non-stop codons mean that target cells are genetically modified for continuous replication. “cDNA” is complimentary DNA used for human cloning and genetically modifying an organism.

Here’s the SLC18A2 cDNA gene patent for transfection of the human genome. Here’s the SLC18A2 ENSG00000165646 synthetic patent for editing the human VMAT2 genes and for the knockout by synthetic “protein encoding.” Here’s the SLC18A2 mRNA gene for VMAT2 deletion and external regulation found on the NIH website.

Here are the SLC18A2 “human gene” mRNA vector kits using CRISPR.

Here’s another SLC18A1 (Solute Carrier Family 18 (Vesicular Monoamine) Member 1) vector sold online. Here’s a VMAT2 Human vector kit called Q05940 · VMAT2_HUMAN for human transfection. That page explains how the cDNA vector will be externally controlled and regulated by “impulse-dependent release.” So, the neurotransmitters from the VMAT2 gene can be externally regulated with this technology.

cDNA (complementary DNA) is used to modify animals or humans genetically for patent eligibility. According to a 2013 US Supreme Court ruling, altering humans with cDNA makes them patent eligible. The court documents show that cDNA is made using modified bacteria. The Supreme Court judges ruled that cDNA added to target cells in the human genome makes a person patent eligible. This would explain why the “antigen” in COVID-19 vaccines is a DARPA hydrogel called Alyhydrogel, which is genetically modified Anthrax and E. coli-based cDNA.

---

Read more: Covid-19 Patent Horrors

---

A study was performed in 2020 where genetic knockout of the VMAT2 gene in the brain using mRNA technology was tested on mice. VMAT1 is also a protein regulator like VMAT2. Knockouts of the VMAT1 and VMAT2 induce schizophrenia. Knockout of the VMAT1 induces schizophrenia and bipolar depression, autism, anxiety, and neuroticism.

A 2022 study conducted a 50% knockout of the VMAT2 in the brain of mice induced Parkinson’s disease. In humans, the VMAT2 deletion induces autoimmune dysregulation, cerebral palsy, and hypoxic-ischemic encephalopathy.

In the American Journal of Human Genetics, a study using Loss-of-Function gene deletions targeting the VMAT2 gene showed that this induces what has been dubbed an “Intellectual Disability Syndrome” in humans.

A study was done on children in 2022 using Loss-of-Function knockout of the VMAT2 gene-induced “brain monoamine vesicular transport disease.” This is an infantile-onset movement disorder that mimics cerebral palsy. Among the 58 affected children from the study, 16 (28%) of them died before the age of 13 years.

In another study, VMAT2 gene knockout induced Parkinson’s and type 1 diabetes, expressed in neurons in the brain. Genetic knockouts of the VMAT2 gene on chromosome 10 lineage are how pharmaceutical companies create type 1 diabetes. This begs the question: Just how long has this technology been deployed against humans through vaccinations without our Informed Consent? How long have pharma and the government been reducing our humanity through VMAT2 knockouts?

Other studies confirm that SLC18A2 (VMAT2 knockout) induces diseases such as Parkinsonism-Dystonia 2, Infantile-Onset, and Infantile Parkinsonism-Dystonia 2.

Here’s the SLC18A1 mRNA gene kit from GeneCards, a human gene database.

A CRISPR/Cas9-mediated VMAT2 knockdown and knockout study from 2021 induced Alzheimer’s in mice.

CRISPR/Cas9-mediated VMAT2 knockdown studies have also been performed to investigate the effects on behavior. VMAT2 deletion causes neuronal loss, which may explain why vaccine-injured patients present with severe neurological issues.

A 2017 study demonstrates that with VMAT2 deletions and regulation of neurotransmitters, Parkinson’s disease motor symptoms can be induced without neuronal degeneration by eliminating dopamine vesicular stocks in the nigrostriatal pathway.

VMAT2 gene knockout increases fearfulness. I have witnessed all of my vaccinated clients being highly fearful.

VMAT2 knockout also induces psychiatric disorders, which have been widely reported. A recent review of the literature shows psychiatric manifestations after the COVID-19 vaccinations, with psychosis being the most common manifestation, followed by altered mental states, functional neurological disorder, mania, depression, and schizophrenia, following COVID-19 vaccination with the Covishield vaccine.

VMAT2 knockout induces aging and cardiac arrhythmia.

China did a study using SLC18A1 mRNA deletions on the VMAT2 gene, demonstrating this will induce cancer.

Here is a VMAT2 (SLC18A2) Human Gene Knockout Kit with CRISPR.

GeneCode offers a SLC18A2 (Solute Carrier Family 18 Member A2) Protein Coding gene specifically targeting the VMAT1 gene. This vector targets the amygdala and prefrontal brain regions related to emotional processing in response to environmental stimuli. VMAT2 deletion in these regions of the brain induces schizophrenic tendencies.

Here’s a VMAT2 (SLC18A2) Human Gene Knockout Kit using CRISPR.

Here’s a P54219 · VMAT1_HUMAN to alter gene expression in the amygdala and prefrontal brain to modulate human emotions and processing.

Here’s a Q05940 · VMAT2_HUMAN for gene regulation of the serotonin and histamine neurotransmitters using the pharmaceutical drugs reserpine and tetrabenazine. Reserpine is an antipsychotic drug that is an uptake inhibitor. The Resperine patent says it’s an “environmental contaminant,” so how can it be good for your brain cells?

Here is an Anti-Vesicular Monoamine Transporter 2 carrier from a goat that targets the VMAT2 gene in humans. “Peptide blocking” means knocking down or knocking out the VMAT2 gene. Polyclonal antibodies are used to target the B-cell Lymphocytes. This carrier is used in “monoclonal antibodies” to target the VMAT2 gene in humans.

Here’s an Anti-Slc18a2/VMAT2 Antibody (N449/73) that targets the VMAT2 gene in the human brain, specifically the hippocampus, cerebral cortex, and cerebellum.

Testing was done for “genetic medications” targeting the VMAT2 gene in 2016, enabling pharmaceutical companies to include VMAT2 knockout technology in their products.

Here’s a VMAT2 antibody in Tris saline, 0.02% sodium azide, pH 7.3, with 0.5% bovine serum albumin for humans. Pharma is calling its Loss-Of-Function bioweapons “antibodies” to fit in with Vaccinology terminology.

Anti-SLC18A2 Antibody Products sold by Biocompare are genetic tagging kits that target the VMAT2 for genetic deletions. Thus, the SLC18A2 vector is being called an “antibody.”

In conclusion to this horrifying information, my advice is to boycott Pharma entirely and learn natural cures to disease imbalances. While genetic knockouts have affected the masses without Informed Consent, it is possible to detox the spike protein and reverse cellular injury caused by the mRNA technology.

In an interview with James Delingpole, I explained how the human body’s intelligent design reverses mRNA damage.

If you would like a health consultation for customized protocol support, please schedule a consultation with me here.

Follow me on Telegram @drloveariyana.

Follow me on X @drloveariyana.